| 1 |
Avanir Pharmaceuticals Inc. v. Ranbaxy Laboratories Limited et al |
1:14-cv-00792 |
D.Del. |
|
|
|
|
| 2 |
Teijin Limited et al v. Ranbaxy Pharmaceuticals Inc. et al |
1:14-cv-00117 |
D.Del. |
|
|
|
|
| 3 |
Teijin Limited et al v. Ranbaxy Pharmaceuticals Inc. et al |
1:14-cv-00117 |
D.Del. |
|
|
|
|
| 4 |
Teijin Limited et al v. Ranbaxy Pharmaceuticals Inc. et al |
1:14-cv-00117 |
D.Del. |
|
|
|
|
| 5 |
Forest Laboratories Inc. et al v Ranbaxy Inc. et al |
1:13-cv-01607 |
D.Del. |
|
|
|
|
| 6 |
Forest Laboratories Inc. et al v Ranbaxy Inc. et al |
1:13-cv-01607 |
D.Del. |
|
|
|
|
| 7 |
Forest Laboratories Inc. et al v Ranbaxy Inc. et al |
1:13-cv-01607 |
D.Del. |
|
|
|
|
| 8 |
Acura Pharmaceuticals Inc. v. Ranbaxy Inc. et al |
1:13-cv-00750 |
D.Del. |
|
|
|
|
| 9 |
WARNER CHILCOTT COMPANY, LLC et al v. RANBAXY, INC. et al |
2:12-cv-02474 |
D.N.J. |
|
|
|
|
| 10 |
WARNER CHILCOTT COMPANY, LLC et al v. RANBAXY, INC. et al |
2:12-cv-02474 |
D.N.J. |
|
|
|
|
| 11 |
Purdue Pharma L.P. et al v. Ranbaxy Inc. et al |
1:11-cv-07104 |
S.D.N.Y. |
|
|
|
|
| 12 |
Purdue Pharma L.P. et al v. Ranbaxy Inc. et al |
1:11-cv-07104 |
S.D.N.Y. |
|
|
|
|
| 13 |
Purdue Pharma L.P. et al v. Ranbaxy Inc. et al |
1:11-cv-07104 |
S.D.N.Y. |
|
|
|
|
| 14 |
Lupin Atlantis Holdings SA v. Ranbaxy Laboratories Limited et al |
1:10-cv-00659 |
D.Del. |
|
|
|
|
| 15 |
Pfizer Inc. et al v. Ranbaxy Laboratories Limited et al |
1:07-cv-00138 |
D.Del. |
|
|
|
|
| 16 |
Pfizer Inc. et al v. Ranbaxy Laboratories Limited et al |
1:07-cv-00138 |
D.Del. |
|
|
|
|
| 17 |
Pfizer Inc. et al v. Ranbaxy Laboratories Limited et al |
1:07-cv-00138 |
D.Del. |
|
|
|
|
| 18 |
Pfizer Inc. et al v. Ranbaxy Laboratories Limited et al |
1:07-cv-00138 |
D.Del. |
|
|
|
|
| 19 |
Pfizer Inc. et al v. Ranbaxy Laboratories Limited et al |
1:07-cv-00138 |
D.Del. |
|
|
|
|
| 20 |
Pfizer Inc. et al v. Ranbaxy Laboratories Limited et al |
1:07-cv-00138 |
D.Del. |
|
|
|
|
| 21 |
Pfizer Inc. et al v. Ranbaxy Laboratories Limited et al |
1:07-cv-00138 |
D.Del. |
|
|
|
|
| 22 |
Pfizer Inc. et al v. Ranbaxy Laboratories Limited et al |
1:07-cv-00138 |
D.Del. |
|
|
|
|
| 23 |
ASTRAZENECA AB et al v. RANBAXY PHARMACEUTICALS, INC. et al |
3:05-cv-05553 |
D.N.J. |
|
|
|
|
| 24 |
ASTRAZENECA AB et al v. RANBAXY PHARMACEUTICALS, INC. et al |
3:05-cv-05553 |
D.N.J. |
|
|
|
|
| 25 |
ASTRAZENECA AB et al v. RANBAXY PHARMACEUTICALS, INC. et al |
3:05-cv-05553 |
D.N.J. |
|
|
|
|
| 26 |
ASTRAZENECA AB et al v. RANBAXY PHARMACEUTICALS, INC. et al |
3:05-cv-05553 |
D.N.J. |
|
|
|
|
| 27 |
ASTRAZENECA AB et al v. RANBAXY PHARMACEUTICALS, INC. et al |
3:05-cv-05553 |
D.N.J. |
|
|
|
|
| 28 |
ASTRAZENECA AB et al v. RANBAXY PHARMACEUTICALS, INC. et al |
3:05-cv-05553 |
D.N.J. |
|
|
|
|
| 29 |
ASTELLAS PHARMA, INC. et al v. RANBAXY, INC. et al |
3:05-cv-02563 |
D.N.J. |
|
|
|
|
| 30 |
ASTELLAS PHARMA, INC. et al v. RANBAXY, INC. et al |
3:05-cv-02563 |
D.N.J. |
|
|
|
|
| 31 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
| 32 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
| 33 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
| 34 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
| 35 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|